FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Amivas (Us) Artesunate for Injection Recall

Artesunate for Injection, 110 mg/vial, packaged in a) 2x2 pack containing 2 Single-dose…

AMIVAS (US), LLC · Frederick, MD

Risk level
Class II
Reported by FDA
Oct 13, 2021
Recall ID
D-0002-2022
Check your lot numberHow we source this data

Summary

Amivas (Us) recalled Artesunate for Injection starting Sep 27, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0002-2022 on Oct 13, 2021. Reason: Lack of Assurance of Sterility: Air filter failed post integrity test leading to a lack of sterility assurance. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Air filter failed post integrity test leading to a lack of sterility assurance.

Product description

Artesunate for Injection, 110 mg/vial, packaged in a) 2x2 pack containing 2 Single-dose vials artesunate (73607-001-01) and 2 vials sterile diluent (NDC 73607-001-02) per carton (NDC 73607-001-11); 4x4 pack containing 4 Single-dose vials artesunate (73607-001-01) and 4 vials sterile diluent (NDC 73607-001-02) per carton (NDC 73607-001-10), Rx only, Mfg for: Amivas, LLC, 1209 Orange St., Wilmington, Delaware 19801.

Lot numbers, UPCs & expiration codes

Manufacturer Lot Numbers: AR479E01, exp. date 11/03/2022; AR479E02, exp. date 11/09/2022; AR479E03, exp. date 11/16/2022; Cardinal Health Packaging Solutions Lot Numbers: 7507001 and 7508001

Where it was sold

Product was distributed to 3 major distributors who may have further distributed the product to various medical centers, hospitals and hospital pharmacies nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0002-2022
Classification
Class II
Status
Terminated
Recall initiated
Sep 27, 2021
FDA report date
Oct 13, 2021
Quantity
292 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
AMIVAS (US), LLC

Original FDA data

Every field from FDA enforcement report D-0002-2022, exactly as published.

Show all FDA fields
City
Frederick
State
MD
Status
Terminated
Country
United States
Event ID
88772
Address
100 Tuscanney Dr Suiteb2
Code information
Manufacturer Lot Numbers: AR479E01, exp. date 11/03/2022; AR479E02, exp. date 11/09/2022; AR479E03, exp. date 11/16/2022; Cardinal Health Packaging Solutions Lot Numbers: 7507001 and 7508001
Postal code
21702
Report date
Oct 13, 2021
Product type
Drugs
Recall number
D-0002-2022
Classification
Class II
Recalling firm
AMIVAS (US), LLC
Product quantity
292 cartons
Termination date
Jun 27, 2023
Reason for recall
Lack of Assurance of Sterility: Air filter failed post integrity test leading to a lack of sterility assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Artesunate for Injection, 110 mg/vial, packaged in a) 2x2 pack containing 2 Single-dose vials artesunate (73607-001-01) and 2 vials sterile diluent (NDC 73607-001-02) per carton (NDC 73607-001-11); 4x4 pack containing 4 Single-dose vials artesunate (73607-001-01) and 4 vials sterile diluent (NDC 73607-001-02) per carton (NDC 73607-001-10), Rx only, Mfg for: Amivas, LLC, 1209 Orange St., Wilmington, Delaware 19801.
Distribution pattern
Product was distributed to 3 major distributors who may have further distributed the product to various medical centers, hospitals and hospital pharmacies nationwide in the USA.
Recall initiation date
Sep 27, 2021
Initial firm notification
Letter
Center classification date
Oct 5, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0002-2022, published Oct 13, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls